Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hyperion Therapeutics Inc (HPTX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hyperion Therapeutics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1386858.
Total stock buying since 2014: $0.
Total stock sales since 2014: $25,700,376.
Total stock option exercises since 2014: $2,340,912.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2015 | 0 | $0 | 74,700 | $2,392,825 | 498,896 | $2,205,671 |
| 2014 | 0 | $0 | 842,319 | $23,307,551 | 31,810 | $135,241 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2015-05 | 0 | $0 | 0 | $0 | 478,896 | $2,124,071 |
| 2015-03 | 0 | $0 | 39,900 | $1,371,472 | 20,000 | $81,600 |
| 2015-02 | 0 | $0 | 29,800 | $897,278 | 0 | $0 |
| 2015-01 | 0 | $0 | 5,000 | $124,075 | 0 | $0 |
| 2014-12 | 0 | $0 | 0 | $0 | 1,093 | $4,459 |
| 2014-10 | 0 | $0 | 0 | $0 | 15,021 | $41,394 |
| 2014-07 | 0 | $0 | 200 | $5,600 | 0 | $0 |
| 2014-06 | 0 | $0 | 842,119 | $23,301,951 | 15,696 | $89,388 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-05-01 | Nash Christine A (SVP & Chief Commercial Officer) | Option Ex | 59,087 | 4.22 | 249,524 |
| 2015-05-01 | Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) | Option Ex | 6,975 | 5.70 | 39,722 |
| 2015-05-01 | Farrow Jeffrey S (CFO) | Option Ex | 120,777 | 4.98 | 601,469 |
| 2015-05-01 | Santel Donald J (CEO & President) | Option Ex | 292,057 | 4.22 | 1,233,356 |
| 2015-03-17 | Nash Christine A (SVP & Chief Commercial Officer) | Sale | 10,000 | 37.56 | 375,600 |
| 2015-03-17 | Nash Christine A (SVP & Chief Commercial Officer) | Option Ex | 10,000 | 4.08 | 40,800 |
| 2015-03-10 | Nash Christine A (SVP & Chief Commercial Officer) | Sale | 11,450 | 32.59 | 394,445 |
| 2015-03-10 | Nash Christine A (SVP & Chief Commercial Officer) | Option Ex | 10,000 | 4.08 | 40,800 |
| 2015-03-09 | Nash Christine A (SVP & Chief Commercial Officer) | Sale | 8,450 | 29.66 | 250,627 |
| 2015-02-27 | Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) | Sale | 29,800 | 30.11 | 897,278 |
| 2015-01-20 | Nash Christine A (SVP & Chief Commercial Officer) | Sale | 5,000 | 24.82 | 124,075 |
| 2014-12-23 | Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) | Option Ex | 1,093 | 4.08 | 4,459 |
| 2014-10-20 | Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) | Option Ex | 5,021 | 5.70 | 28,594 |
| 2014-10-15 | Nash Christine A (SVP & Chief Commercial Officer) | Option Ex | 10,000 | 1.28 | 12,800 |
| 2014-07-02 | Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) | Sale | 200 | 28.00 | 5,600 |
| 2014-06-18 | Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) | Option Ex | 10,464 | 5.70 | 59,592 |
| 2014-06-06 | Drant Ryan D (10% Owner) | Sale | 1,134 | 26.90 | 30,505 |
| 2014-06-06 | Baskett Forest (10% Owner) | Sale | 1,377 | 26.89 | 37,022 |
| 2014-06-06 | Kolluri Krishna Kittu (10% Owner) | Sale | 120 | 27.19 | 3,262 |
| 2014-06-06 | Sandell Scott D (10% Owner) | Sale | 1,430 | 13.37 | 19,119 |
| 2014-06-06 | Barrett M James (10% Owner) | Sale | 1,430 | 26.82 | 38,356 |
| 2014-06-06 | Barris Peter J (10% Owner) | Sale | 1,134 | 26.90 | 30,505 |
| 2014-06-04 | Healy James (Director) | Sale | 417,747 | 27.70 | 11,571,591 |
| 2014-06-04 | Powell Michael (10% Owner) | Sale | 417,747 | 27.70 | 11,571,591 |
Insider trading activities including stock purchases, stock sales, and option exercises of HPTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hyperion Therapeutics Inc (symbol HPTX, CIK number 1386858) see the Securities and Exchange Commission (SEC) website.